Compare CADL & MTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | MTW |
|---|---|---|
| Founded | 1999 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 416.9M |
| IPO Year | 2021 | 1994 |
| Metric | CADL | MTW |
|---|---|---|
| Price | $5.04 | $11.70 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 4 |
| Target Price | ★ $19.00 | $10.50 |
| AVG Volume (30 Days) | ★ 1.2M | 202.8K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $125,000.00 | ★ $2,240,900,000.00 |
| Revenue This Year | N/A | $4.73 |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | ★ N/A | $58.75 |
| Revenue Growth | N/A | ★ 2.89 |
| 52 Week Low | $4.25 | $7.06 |
| 52 Week High | $7.24 | $15.56 |
| Indicator | CADL | MTW |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 40.68 |
| Support Level | $4.58 | $9.87 |
| Resistance Level | $5.42 | $13.32 |
| Average True Range (ATR) | 0.25 | 0.50 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 70.00 | 47.92 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.